Stage 3 cirrhosis, often called decompensated cirrhosis, carries a median survival time of about 2 years without a liver transplant. That number is a population average, though, and individual outcomes vary widely depending on how your liver is functioning, what complications you’re dealing with, and how well you respond to treatment. Some people live well beyond that median, while others face a shorter timeline if complications stack up quickly.
What Stage 3 Cirrhosis Means
Cirrhosis staging is based on whether the liver can still do its job despite the scarring. In stages 1 and 2, the liver is “compensated,” meaning it’s damaged but still functioning well enough that you may not have noticeable symptoms. Median survival in compensated cirrhosis exceeds 12 years.
Stage 3 marks the shift to decompensation. This is when the liver can no longer keep up, and complications start appearing. The hallmark of stage 3 is fluid buildup in the abdomen, called ascites, which is the most common complication of cirrhosis. You may also develop confusion or mental fogginess from toxins the liver can no longer filter (hepatic encephalopathy), or bleeding from swollen veins in the esophagus or stomach (varices). The arrival of any one of these complications is what moves the diagnosis from compensated to decompensated.
How Survival Is Estimated
Doctors use two main scoring systems to predict outcomes. The Child-Pugh score groups patients into classes A, B, and C based on liver function tests, the severity of ascites, and mental status. Most people with stage 3 cirrhosis fall into Child-Pugh Class B or C. A large multicenter study found the following survival rates:
- Class A: 90% survival at 1 year, 61% at 5 years
- Class B: 78% survival at 1 year, 42% at 5 years
- Class C: 65% survival at 1 year, 25% at 5 years
The MELD score is the other key tool, and it’s the one used to prioritize patients for liver transplant. It’s calculated from blood tests measuring kidney function, clotting ability, and bilirubin levels. A MELD score between 10 and 19 carries a 6% chance of dying within 90 days. A score between 20 and 29 raises that 90-day risk to about 20%. The higher the MELD score, the more urgently a transplant is needed.
What People Actually Die From
In a long-term study following over 500 cirrhosis patients for up to 16 years, 57% of deaths were directly liver-related. The biggest single cause was liver failure, accounting for 24% of deaths. Another 14% died from gastrointestinal bleeding alone, and 13% from the combination of liver failure and bleeding. Infections caused 7% of deaths. Cardiovascular disease was responsible for 22%, a reminder that heart health still matters even with a serious liver condition. Cancers outside the liver accounted for 9%.
Liver cancer is another real concern. In people with cirrhosis, the annual incidence of hepatocellular carcinoma ranges from 1% to 8%, depending on the underlying cause. If your cirrhosis stems from treated hepatitis C, suppressed hepatitis B, alcohol-related liver disease, or fatty liver disease, the yearly risk is on the lower end, around 1% to 2%. That risk compounds over time, which is why regular screening with imaging is standard care.
What Affects How Long You Live
The underlying cause of cirrhosis matters. If the cause is still active, like ongoing heavy drinking or untreated hepatitis, the liver deteriorates faster. Removing the cause won’t reverse the scarring, but it can slow progression dramatically and sometimes allow partial recompensation, where the liver stabilizes enough that some complications ease.
Nutrition plays a surprisingly large role. European clinical nutrition guidelines recommend that people with cirrhosis consume 1.2 to 1.5 grams of protein per kilogram of body weight daily, which is higher than what most healthy adults need. A prospective study of cirrhosis survivors found that those who met that protein target had significantly lower mortality, with risk dropping by roughly 62% compared to those eating the least protein. The source of protein mattered too: dairy and plant-based proteins were associated with lower death rates, while higher intake of animal protein (primarily meat) was linked to increased mortality risk, especially in patients with more severe disease.
Malnutrition is extremely common in advanced cirrhosis and accelerates muscle wasting, weakens the immune system, and makes complications harder to recover from. Getting enough calories, generally around 2,000 per day or more, with adequate protein from dairy and plant sources, is one of the few things within your direct control that has a measurable impact on survival.
Managing Complications
Much of the medical care for stage 3 cirrhosis focuses on controlling the complications that define it. Ascites is typically managed with a low-sodium diet and diuretics to reduce fluid retention. When ascites becomes resistant to medication, procedures to drain the fluid or redirect blood flow through the liver may be needed.
For variceal bleeding, or to prevent it from happening in the first place, blood pressure-lowering medications that reduce pressure in the portal vein are a mainstay of treatment. Large studies have shown that patients with ascites who take these medications have lower mortality than those who don’t. The benefit extends to patients who have had serious abdominal infections as well, with death rates dropping from about 11.5% to 10.3% in that group. These medications aren’t appropriate for everyone, particularly if blood pressure or kidney function is already compromised, but they are a proven tool for extending survival in the right patients.
Hepatic encephalopathy, the brain fog and confusion caused by toxin buildup, is managed with medications that reduce ammonia levels in the gut. Episodes can range from subtle difficulty concentrating to serious disorientation, and recurrent episodes are associated with worse overall prognosis.
Liver Transplant as a Path Forward
A liver transplant is the only treatment that can effectively cure cirrhosis, and it dramatically changes the survival outlook. Current U.S. data shows that about 93% of transplant recipients survive at least one year, and roughly 80% are alive at five years. Compare that to the 42% five-year survival for Class B cirrhosis patients and 25% for Class C without transplant, and the difference is stark.
Not everyone qualifies. The evaluation process considers your overall health, whether other organs are functioning well enough to survive major surgery, and whether the underlying cause of liver disease has been addressed. Active alcohol use or untreated addiction typically disqualifies candidates, though policies vary by transplant center. Wait times depend on your MELD score and regional organ availability. Living-donor transplantation, where a healthy person donates a portion of their liver, is an option that can shorten or bypass the waiting list entirely.
For people who aren’t transplant candidates, the focus shifts to managing complications aggressively, maintaining nutrition, and addressing the root cause of liver damage to slow further decline. Even without transplant, many people live years beyond their initial decompensation when complications are well controlled.